42
Participants
Start Date
March 10, 2022
Primary Completion Date
June 23, 2023
Study Completion Date
June 23, 2023
Actigraph
Participants will wear an Actigraph hip-worn accelerometer on their non-dominant hip during all waking hours, and on the wrist while sleeping
Questionnaires
"* Patient Health Questionnaire Anxiety and Depression Scale30 (PHQ-ADS), a validated composite of anxiety and depressive symptoms.~* Self-reported cognition will be assessed by the Functional Assessment of Cancer Therapy-Cognitive (FACT-Cog)."
BrainBaseline application
Objective measures of cognitive function will include those from the BrainBaseline application, a validated research tool developed by Digital Artefacts to remotely measure domains of cognition
Semi-structured interviews
Semi-structured individual interviews will be conducted with up to 15 healthcare stakeholders and 15-30 patients with breast cancer at any time during the study period, as determined by participant preference.
Washington University School of Medicine, St Louis
National Institute of Mental Health (NIMH)
NIH
Washington University School of Medicine
OTHER